RecruitingNot ApplicableNCT07190755

Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC)

Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Curative Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC) With Radiotherapy or Chemoradiotherapy


Sponsor

Centre Henri Becquerel

Enrollment

192 participants

Start Date

Oct 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The use of digital strategies to systematically monitor patients' symptoms in clinical settings allows problems to be detected at an early stage before they worsen or lead to complications. In this study, the hypothesis is that the proportion of patients with a weight loss of at least 5% between before radiotherapy/radiochemotherapy and 3 months after treatment would be lower with optimised care thanks to remote monitoring using a medical telemonitoring solution in oncology.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether using a digital tool for patients to report their own symptoms during treatment for head and neck cancer improves how quickly problems are caught and managed. Patients will log symptoms using a smartphone or internet-connected device. **You may be eligible if...** - You are between 18 and 75 years old - You have localised squamous cell carcinoma (a common type) of the head and neck, being treated with the goal of cure using radiation therapy or chemoradiotherapy - You have a smartphone or internet access - You are covered by a social health insurance scheme in France **You may NOT be eligible if...** - You have had another cancer in the past 2 years - You have had prior radiation to the head and neck area - You are pregnant or breastfeeding - You are participating in another clinical treatment trial - You have barriers to using the digital symptom-reporting tool (language, vision, psychological, or geographical factors) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRemote symptoms moniotring

Participants in the intervention arm will use Resilience PRO, a mobile phone application regularly asking participants about their symptoms. For clinically important symptoms, an alert is sent to the care team that can incorporate that information to timely adjust the care of the participants.


Locations(2)

Centre Henri Becquerel

Rouen, France

Institut de Cancérologie de Lorraine

Vandœuvre-lès-Nancy, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07190755


Related Trials